PMID- 18625328 OWN - NLM STAT- MEDLINE DCOM- 20090116 LR - 20131121 IS - 1095-9564 (Electronic) IS - 1074-7427 (Linking) VI - 90 IP - 3 DP - 2008 Oct TI - BDNF reverses the CTA memory deficits produced by inhibition of protein synthesis. PG - 584-7 LID - 10.1016/j.nlm.2008.06.003 [doi] AB - Brain-derived neurotrophic factor (BDNF) is an essential protein synthesis product that has emerged as one of the most potent molecular mediators of not only central synaptic plasticity, but also behavioral interactions between an organism and its environment. Our previous studies on the insular cortex (IC), a region of the temporal cortex implicated in the acquisition and storage of conditioned taste aversion (CTA), have demonstrated that intracortical microinfusion of BDNF induces a lasting potentiation of synaptic efficacy in the projection from the basolateral nucleus of the amygdala (Bla) to the IC of adult rats in vivo. Recently, we found that intracortical microinfusion of BDNF previous to CTA training enhances the retention of this task. In this work, we present experimental data showing that acute intracortical delivery of BDNF (2 microg/2 microl per side) reverses the deficit in CTA memory caused by inhibition of insular cortex protein synthesis due to anisomycin administration (100 microg/microl per side) in male adult Wistar rats. These findings suggest that BDNF is a protein synthesis product essential for neocortical long-term memory storage. FAU - Moguel-Gonzalez, Minerva AU - Moguel-Gonzalez M AD - Division de Investigacion y Estudios de Posgrado, Facultad de Psicologia, Universidad Nacional Autonoma de Mexico, Av. Universidad 3004, 04510 Mexico D.F., Mexico. FAU - Gomez-Palacio-Schjetnan, Andrea AU - Gomez-Palacio-Schjetnan A FAU - Escobar, Martha L AU - Escobar ML LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080729 PL - United States TA - Neurobiol Learn Mem JT - Neurobiology of learning and memory JID - 9508166 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Nerve Tissue Proteins) RN - 0 (Protein Synthesis Inhibitors) RN - 6C74YM2NGI (Anisomycin) SB - IM MH - Animals MH - Anisomycin/pharmacology MH - Avoidance Learning/drug effects/*physiology MH - Brain-Derived Neurotrophic Factor/administration & dosage/*physiology MH - Conditioning, Classical/drug effects/*physiology MH - Male MH - Microinjections MH - Nerve Tissue Proteins/biosynthesis/drug effects MH - Protein Synthesis Inhibitors/pharmacology MH - Rats MH - Rats, Wistar MH - Signal Transduction/drug effects/physiology MH - Taste MH - Temporal Lobe/drug effects/*physiology EDAT- 2008/07/16 09:00 MHDA- 2009/01/17 09:00 CRDT- 2008/07/16 09:00 PHST- 2008/03/05 00:00 [received] PHST- 2008/06/02 00:00 [revised] PHST- 2008/06/15 00:00 [accepted] PHST- 2008/07/16 09:00 [pubmed] PHST- 2009/01/17 09:00 [medline] PHST- 2008/07/16 09:00 [entrez] AID - S1074-7427(08)00102-0 [pii] AID - 10.1016/j.nlm.2008.06.003 [doi] PST - ppublish SO - Neurobiol Learn Mem. 2008 Oct;90(3):584-7. doi: 10.1016/j.nlm.2008.06.003. Epub 2008 Jul 29.